Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Post by Yellowknifer69on Apr 20, 2021 8:56am
169 Views
Post# 33027885

Re: Manipulators and Market Makers

Re: Manipulators and Market MakersHello and good morning ATE longs:

First off, hope you all are staying well and healthy during the latest Wave 3 of Covid.

I have just picked up on the latest threads regarding some of the shorters who regularly contibute their negative vitriol about Antibe on this board. 

A couple of things that us 'retail investors'  should keep in mind about the Vulture Exchange:

1. Never invest more than you can afford to lose on juniors like Antibe - This compnay is still          trying grow some chops and we have to remember that it can be a 10 or 20 year journey            before your investment comes to fruition.

2.  Use the Ignore button liberally - if you don't like what Duster has to say then put him/her/it 
     on Ignore.  His paid job (and others Like him) is to drive the SP down so that their investors 
     make a better ROI than we do.

3.  I really hate to admit this but.....sometimes these bottom feeders are more correct than us 
     'pie in the sky' hopefuls who think that everyday is going to be green across the investment
     board. 

Anyways, stay long on ATE - Dan and the Co are cooking up a nice dinner for us - just taking a lot longer to prepare!

Come on Dan - feed us some news and lets get er' rolling!

Yellowknifer 

<< Previous
Bullboard Posts
Next >>